In good tidings about the possible vaccine against the emerging corona virus, the British pharmaceutical company, AstraZeneca, said: The “Covid-19” vaccine, developed by the University of Oxford, stimulates a similar immune response in the elderly and young people, and the negative response was less among the elderly. While identical sources stated that this vaccine will be in British hospitals, starting next week. A spokesperson for “AstraZeneca” said: “It is very encouraging to see that the immune response was similar in the elderly and the young.” “The results reinforce the set of evidence for the safety and immunity of AZ1222,” he added, referring to the technical name of the vaccine.
The Oxford AstraZeneca vaccine is expected to be the first vaccine from the major pharmaceutical companies to gain approval from regulatory agencies, along with a candidate vaccine from Pfizer and Biontech. If successful, the vaccine would allow the world to return to some level of normality.
The Sun newspaper said that the heads of health in London are ready to start the delivery of vaccine stocks starting from next week, indicating that workers in a major London hospital have been asked to be ready to receive the first batches of the Oxford AstraZeneca vaccine, as of 2 Nov. The newspaper mentioned that other clinical trials in a famous hospital have been temporarily stopped, as all resources are directed towards preparing to vaccinate thousands of doctors, nurses and other frontline workers.
In turn, Dr. Adrian Hill, who is leading the Oxford vaccine project, announced that doctors and patients at high risk will likely receive the vaccine before the end of the year under emergency approval, indicating that this means that the rest of the population can receive the vaccine in early 2021. The professor admitted Hill, founder and director of the Jenner Institute at the University of Oxford, says “billions of doses” are already being produced at ten plants around the world by a consortium led by the British pharmaceutical company AstraZeneca.
“I would be very surprised if the Corona risk did not decrease by spring,” he added.
In a related context, the Russian company “Biocad”, which specializes in the production of medicines, announced its intention to start industrial production of the Russian vaccine, “Sputnik-V”, before next December, and is currently working on adapting its production technologies to the standards of the vaccine that was developed in the “Gamalia” center. ».
This, and the Israeli Mossad was able to transfer doses of the Chinese Corona vaccine and subject it to tests in the country in order to study it and learn how it works, according to what was reported by the Jerusalem Post.
Arab countries most affected by the epidemic
According to international statistics prepared by Johns Hopkins University, 42884475 cases were recorded as of Sunday, October 25, 2020. The following are the Arab countries most affected by the epidemic.
1 – Iraq: The first Arab country in terms of the number of confirmed injuries, 451,707 injuries and 10,623 deaths.
2 – Saudi Arabia: The number of injuries has reached 344,875 confirmed cases, while 5296 have died so far.
3 – Morocco: The number of injured reached 197,481, and 3301 died as of Sunday.
4 – Qatar: The number of injured reached 131,170, while Doha announced the death of 230 people.
5 – UAE: 125,123 confirmed cases.
Al Qabas readers are browsing now